Clinical trial

A Study of LY2216684 and Theophylline in Healthy Subjects

NCT01263106

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-12-01

PhasePHASE1

Study timeline

Study start (unknown)2010-12-01Date precision: month

Registry last updated2019-07-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderunresolved

Interventions

LY2216684DRUG

TheophyllineDRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

DallasTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01263106 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.